MIA Syndrome in Peritoneal Dialysis: Prevention and Treatment
Malnutrition, inflammation and atherosclerosis are prevalent in end stage renal disease and constitute the Malnutrition-Inflammation-Atherosclerosis Syndrome. The syndrome is associated with high cardiovascular mortality and accounts for most of the premature deaths in peritoneal dialysis patients....
Gespeichert in:
| Veröffentlicht in: | Contributions to nephrology 2006-01, Vol.150, p.135-143 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 143 |
|---|---|
| container_issue | |
| container_start_page | 135 |
| container_title | Contributions to nephrology |
| container_volume | 150 |
| creator | Shahab, Irum Nolph, Karl D. |
| description | Malnutrition, inflammation and atherosclerosis are prevalent in end stage renal disease and constitute the Malnutrition-Inflammation-Atherosclerosis Syndrome. The syndrome is associated with high cardiovascular mortality and accounts for most of the premature deaths in peritoneal dialysis patients. Presence of elevated C-reactive protein levels correlates with malnutrition, decreased fluid removal and mortality in these patients. Early recognition of the syndrome is important to identify high risk patients. Nutritional support, changes in dialysis and drug therapy may decrease the cardiovascular morbidity and mortality. |
| doi_str_mv | 10.1159/000093513 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_karge</sourceid><recordid>TN_cdi_pubmed_primary_16721003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16721003</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-ee44a7a9caaafa5f7e0afdae49bc1fe8801d935daea9c7923da1f2272a87ef813</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhuMXttYe_AOSg9fVTLLbJEIPpX4VKhas4G2ZdieytrtbklXovzdaPTuXgXceXniGsTMQlwCZvRJxrMpA7bETpcAIUKmGfdaFwUAmUht5EA9GZJkBsK-HrCuUkEkGadph_RDevwskWKvFMevAQEsQQnXZ8HEy4s_buvBNRbys-Yx82TY14ZrflLjehjJc85mnT6rbsqk51gWfe8K2isEpO3K4DtT_3T32cnc7Hz8k06f7yXg0TZZKqDYhSlPUaJeI6DBzmgS6Aim1iyU4MtGmiHIxiYy2UhUITkot0WhyBlSPne96Nx-Liop848sK_Tb_84gA3wEr9G_kc1o0zSqE6EIh__lbRC7-QfJN4dQXHVlmXg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>MIA Syndrome in Peritoneal Dialysis: Prevention and Treatment</title><source>MEDLINE</source><source>Karger Book Series</source><creator>Shahab, Irum ; Nolph, Karl D.</creator><contributor>Ronco C ; Dell’Aquila R ; Rodighiero MP</contributor><creatorcontrib>Shahab, Irum ; Nolph, Karl D. ; Ronco C ; Dell’Aquila R ; Rodighiero MP</creatorcontrib><description>Malnutrition, inflammation and atherosclerosis are prevalent in end stage renal disease and constitute the Malnutrition-Inflammation-Atherosclerosis Syndrome. The syndrome is associated with high cardiovascular mortality and accounts for most of the premature deaths in peritoneal dialysis patients. Presence of elevated C-reactive protein levels correlates with malnutrition, decreased fluid removal and mortality in these patients. Early recognition of the syndrome is important to identify high risk patients. Nutritional support, changes in dialysis and drug therapy may decrease the cardiovascular morbidity and mortality.</description><identifier>ISSN: 0302-5144</identifier><identifier>ISBN: 380558119X</identifier><identifier>ISBN: 9783805581196</identifier><identifier>EISSN: 1662-2782</identifier><identifier>EISBN: 3318013471</identifier><identifier>EISBN: 9783318013474</identifier><identifier>DOI: 10.1159/000093513</identifier><identifier>PMID: 16721003</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Atherosclerosis - etiology ; Atherosclerosis - prevention & control ; Atherosclerosis - therapy ; Biological Transport ; Chapter ; Cytokines - antagonists & inhibitors ; Dialysis Solutions - adverse effects ; Humans ; Inflammation - etiology ; Inflammation - prevention & control ; Inflammation - therapy ; Malnutrition - etiology ; Malnutrition - prevention & control ; Malnutrition - therapy ; Peritoneal Dialysis - adverse effects ; Peritoneum - metabolism ; Syndrome</subject><ispartof>Contributions to nephrology, 2006-01, Vol.150, p.135-143</ispartof><rights>2006 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c303t-ee44a7a9caaafa5f7e0afdae49bc1fe8801d935daea9c7923da1f2272a87ef813</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,775,776,780,789,24761,26060,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16721003$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ronco C</contributor><contributor>Dell’Aquila R</contributor><contributor>Rodighiero MP</contributor><creatorcontrib>Shahab, Irum</creatorcontrib><creatorcontrib>Nolph, Karl D.</creatorcontrib><title>MIA Syndrome in Peritoneal Dialysis: Prevention and Treatment</title><title>Contributions to nephrology</title><addtitle>Contrib Nephrol</addtitle><description>Malnutrition, inflammation and atherosclerosis are prevalent in end stage renal disease and constitute the Malnutrition-Inflammation-Atherosclerosis Syndrome. The syndrome is associated with high cardiovascular mortality and accounts for most of the premature deaths in peritoneal dialysis patients. Presence of elevated C-reactive protein levels correlates with malnutrition, decreased fluid removal and mortality in these patients. Early recognition of the syndrome is important to identify high risk patients. Nutritional support, changes in dialysis and drug therapy may decrease the cardiovascular morbidity and mortality.</description><subject>Atherosclerosis - etiology</subject><subject>Atherosclerosis - prevention & control</subject><subject>Atherosclerosis - therapy</subject><subject>Biological Transport</subject><subject>Chapter</subject><subject>Cytokines - antagonists & inhibitors</subject><subject>Dialysis Solutions - adverse effects</subject><subject>Humans</subject><subject>Inflammation - etiology</subject><subject>Inflammation - prevention & control</subject><subject>Inflammation - therapy</subject><subject>Malnutrition - etiology</subject><subject>Malnutrition - prevention & control</subject><subject>Malnutrition - therapy</subject><subject>Peritoneal Dialysis - adverse effects</subject><subject>Peritoneum - metabolism</subject><subject>Syndrome</subject><issn>0302-5144</issn><issn>1662-2782</issn><isbn>380558119X</isbn><isbn>9783805581196</isbn><isbn>3318013471</isbn><isbn>9783318013474</isbn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhuMXttYe_AOSg9fVTLLbJEIPpX4VKhas4G2ZdieytrtbklXovzdaPTuXgXceXniGsTMQlwCZvRJxrMpA7bETpcAIUKmGfdaFwUAmUht5EA9GZJkBsK-HrCuUkEkGadph_RDevwskWKvFMevAQEsQQnXZ8HEy4s_buvBNRbys-Yx82TY14ZrflLjehjJc85mnT6rbsqk51gWfe8K2isEpO3K4DtT_3T32cnc7Hz8k06f7yXg0TZZKqDYhSlPUaJeI6DBzmgS6Aim1iyU4MtGmiHIxiYy2UhUITkot0WhyBlSPne96Nx-Liop848sK_Tb_84gA3wEr9G_kc1o0zSqE6EIh__lbRC7-QfJN4dQXHVlmXg</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>Shahab, Irum</creator><creator>Nolph, Karl D.</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20060101</creationdate><title>MIA Syndrome in Peritoneal Dialysis: Prevention and Treatment</title><author>Shahab, Irum ; Nolph, Karl D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-ee44a7a9caaafa5f7e0afdae49bc1fe8801d935daea9c7923da1f2272a87ef813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Atherosclerosis - etiology</topic><topic>Atherosclerosis - prevention & control</topic><topic>Atherosclerosis - therapy</topic><topic>Biological Transport</topic><topic>Chapter</topic><topic>Cytokines - antagonists & inhibitors</topic><topic>Dialysis Solutions - adverse effects</topic><topic>Humans</topic><topic>Inflammation - etiology</topic><topic>Inflammation - prevention & control</topic><topic>Inflammation - therapy</topic><topic>Malnutrition - etiology</topic><topic>Malnutrition - prevention & control</topic><topic>Malnutrition - therapy</topic><topic>Peritoneal Dialysis - adverse effects</topic><topic>Peritoneum - metabolism</topic><topic>Syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shahab, Irum</creatorcontrib><creatorcontrib>Nolph, Karl D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Contributions to nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shahab, Irum</au><au>Nolph, Karl D.</au><au>Ronco C</au><au>Dell’Aquila R</au><au>Rodighiero MP</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MIA Syndrome in Peritoneal Dialysis: Prevention and Treatment</atitle><jtitle>Contributions to nephrology</jtitle><addtitle>Contrib Nephrol</addtitle><date>2006-01-01</date><risdate>2006</risdate><volume>150</volume><spage>135</spage><epage>143</epage><pages>135-143</pages><issn>0302-5144</issn><eissn>1662-2782</eissn><isbn>380558119X</isbn><isbn>9783805581196</isbn><eisbn>3318013471</eisbn><eisbn>9783318013474</eisbn><abstract>Malnutrition, inflammation and atherosclerosis are prevalent in end stage renal disease and constitute the Malnutrition-Inflammation-Atherosclerosis Syndrome. The syndrome is associated with high cardiovascular mortality and accounts for most of the premature deaths in peritoneal dialysis patients. Presence of elevated C-reactive protein levels correlates with malnutrition, decreased fluid removal and mortality in these patients. Early recognition of the syndrome is important to identify high risk patients. Nutritional support, changes in dialysis and drug therapy may decrease the cardiovascular morbidity and mortality.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>16721003</pmid><doi>10.1159/000093513</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0302-5144 |
| ispartof | Contributions to nephrology, 2006-01, Vol.150, p.135-143 |
| issn | 0302-5144 1662-2782 |
| language | eng |
| recordid | cdi_pubmed_primary_16721003 |
| source | MEDLINE; Karger Book Series |
| subjects | Atherosclerosis - etiology Atherosclerosis - prevention & control Atherosclerosis - therapy Biological Transport Chapter Cytokines - antagonists & inhibitors Dialysis Solutions - adverse effects Humans Inflammation - etiology Inflammation - prevention & control Inflammation - therapy Malnutrition - etiology Malnutrition - prevention & control Malnutrition - therapy Peritoneal Dialysis - adverse effects Peritoneum - metabolism Syndrome |
| title | MIA Syndrome in Peritoneal Dialysis: Prevention and Treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T17%3A50%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MIA%20Syndrome%20in%20Peritoneal%20Dialysis:%20Prevention%20and%20Treatment&rft.jtitle=Contributions%20to%20nephrology&rft.au=Shahab,%20Irum&rft.date=2006-01-01&rft.volume=150&rft.spage=135&rft.epage=143&rft.pages=135-143&rft.issn=0302-5144&rft.eissn=1662-2782&rft.isbn=380558119X&rft.isbn_list=9783805581196&rft_id=info:doi/10.1159/000093513&rft_dat=%3Cpubmed_karge%3E16721003%3C/pubmed_karge%3E%3Curl%3E%3C/url%3E&rft.eisbn=3318013471&rft.eisbn_list=9783318013474&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16721003&rfr_iscdi=true |